Related Experiment Video
Updated: Aug 20, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors
Laura Urbanski1, Mattia Brugiolo2, SungHee Park2
1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Graduate Program in Genetics and Development, UConn Health, Farmington, CT, USA.
Abstract:
MYC is dysregulated in >50% of cancers, but direct targeting of MYC has been clinically unsuccessful. Targeting downstream MYC effector pathways represents an attractive alternative. MYC regulates alternative mRNA splicing, but the mechanistic links between MYC and the splicing machinery in cancer remain underexplored. Here, we identify a network of co-expressed splicing factors (SF-modules) in MYC-active breast tumors. Of these, one is a pan-cancer SF-module correlating with MYC activity across 33 tumor types. In mammary cell models, MYC activation leads to co-upregulation of pan-cancer module SFs and to changes in >4,000 splicing events. In breast cancer organoids, co-overexpression of the pan-cancer SF-module induces MYC-regulated splicing events and increases organoid size and invasiveness, while knockdown decreases organoid size. Finally, we uncover a MYC-activity pan-cancer splicing signature correlating with survival across tumor types. Our findings provide insight into the mechanisms of MYC-regulated splicing and for the development of therapeutics for MYC-driven tumors.
Insights
MYC drives cancer by altering gene splicing. Researchers identified a splicing factor module linked to MYC activity across many cancers, offering new therapeutic targets for MYC-driven tumors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genomics
Background:
- MYC oncoprotein dysregulation is common in cancer (>50%) but direct MYC targeting has failed.
- MYC influences alternative mRNA splicing, a mechanism underexplored in cancer.
- Targeting downstream MYC effector pathways is a promising therapeutic strategy.
Purpose of the Study:
- To investigate the mechanistic links between MYC and mRNA splicing machinery in cancer.
- To identify splicing factor modules (SF-modules) associated with MYC activity in tumors.
- To explore the therapeutic potential of targeting MYC-regulated splicing.
Main Methods:
- Identification of co-expressed SF-modules in MYC-active breast tumors.
- Correlation analysis of SF-modules with MYC activity across 33 tumor types.
- Functional studies in mammary cell models and breast cancer organoids.
- Analysis of a pan-cancer splicing signature for survival correlation.
Main Results:
- A pan-cancer SF-module correlating with MYC activity was identified.
- MYC activation in mammary cells caused co-upregulation of SF-module members and altered >4,000 splicing events.
- Overexpression of the SF-module in breast cancer organoids mimicked MYC-regulated splicing, increasing organoid size and invasiveness.
- Knockdown of the SF-module reduced organoid size.
Conclusions:
- MYC activation drives a specific splicing program through co-regulated splicing factors.
- This MYC-driven splicing signature is conserved across multiple cancer types and impacts tumor progression.
- The identified SF-modules and splicing signature represent potential therapeutic targets and biomarkers for MYC-driven cancers.
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

